IDiyas

For the Inventor, By the Inventor

North St. Paul, MN, United States of America

John W Mickelson

USPTO Granted Patents = 26

Average Co-Inventor Count = 4.7

ph-index = 18

Forward Citations = 1,654(Granted Patents)


Location History:

  • Kalamazoo, MN (US) (1993)
  • Mattawan, MI (US) (2003 - 2009)
  • North St. Paul, MN (US) (2000 - 2010)
  • Dexter, MI (US) (2010)
  • Eau Claire, WI (US) (2016)

Company Filing History:

goldMedal20 out of 14,059 
 
3m Innovative Properties Company
 patents
silverMedal3 out of 202 
 
Elan Pharmaceuticals, Inc.
 patents
bronzeMedal2 out of 7 
 
Graceway Pharmaceuticals, LLC
 patents
4. 1 out of 523 
 
Pharmacia & Upjohn Company
 patents
5. 2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1993-2016

Loading Chart...
26 patents (USPTO):Explore Patents
1. 9409184 - Portable sand plant, systems and methods (2016-08-09),
2. 7727997 - N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives (2010-06-01),
3. 7678918 - Intermediates for imidazonaphthyridines (2010-03-16),
4. 7589094 - N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds (2009-09-15),
5. 7335773 - Intermediates for imidazonaphthyridines (2008-02-26),
6. 7176242 - N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives (2007-02-13),
7. 7038051 - Imidazonaphthyridines (2006-05-02),
8. 6989389 - Aryl ether substituted imidazoquinolines (2006-01-24),
9. 6953804 - Aryl ether substituted imidazoquinolines (2005-10-11),
10. 6949646 - Imidazonaphthyridines (2005-09-27),
11. 6894165 - Imidazonaphthyridines (2005-05-17),
12. 6809203 - Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof (2004-10-26),
13. 6797716 - Imidazonaphthyridines (2004-09-28),
14. 6703402 - Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof (2004-03-09),
15. 6677348 - Aryl ether substituted imidazoquinolines (2004-01-13),

Certainly! Here is the article about inventor John W Mickelson:

Title: The Inventive Journey of John W Mickelson: Pioneering Solutions to Medical Challenges

Introduction:

John W Mickelson is a revered inventor hailing from North St. Paul, Minnesota (US) who has made significant contributions to the field of pharmaceuticals and medical research. With an impressive portfolio of 24 patents, Mickelson's innovative spirit shines through in his groundbreaking work.

Latest Patents:

Among his latest patents is the discovery of N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives. These compounds have shown promise as inhibitors of beta-secretase, offering potential treatments for disorders like Alzheimer's Disease. Additionally, Mickelson has developed intermediates for Imidazonaphthyridines, compounds known for inducing the biosynthesis of key cytokines with antiviral and antitumor properties.

Career Highlights:

Throughout his career, John W Mickelson has collaborated with esteemed companies such as 3M Innovative Properties Company and Elan Pharmaceuticals, Inc. His innovative mindset and expertise have led to groundbreaking advancements in pharmaceutical research, positioning him as a trailblazer in the industry.

Collaborations:

Mickelson's work has been enriched by collaborations with notable coworkers like Bryon A Merrill and Michael J Rice. Together, they have shared insights, knowledge, and dedication to pushing the boundaries of medical innovation.

Conclusion:

In conclusion, John W Mickelson's inventive journey is a testament to his passion for creating solutions to complex medical challenges. His remarkable patents and collaborations stand as a testament to his enduring impact on the field of healthcare and pharmaceuticals. Mickelson's legacy continues to inspire future generations of inventors to push the boundaries of innovation in pursuit of a better tomorrow.

If you need further information or assistance, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…